Respiratory viruses Human rhino/enteroviruses were the most commonly detected respiratory viruses during January 2024.Similar to December 2023, SARS-CoV-2 detection rates were in the range of 10-12%.Percentage positivity for the other respiratory viruses remained...
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during 2023, with additional data from December 2023. As with the monthly respiratory pathogen reports, the data is dependent on...
Influenza, respiratory syncytial virus (RSV) and SARS-CoV-2 • Influenza A and RSV detection rates remained low during November (≤ 2%). • The highest detection rates for influenza B percentage occurred in week 47 at 8%. • SARS-CoV-2 detection rates in weeks 44 - 47...
Influenza, respiratory syncytial virus (RSV) and SARS-CoV-2 Influenza A and RSV detection rates were below 2% during October. Influenza B cases continued to be detected during October with positivity rates reaching 5% in weeks 42 and 43, but remained below the...
Influenza A, influenza B and RSV detection rates were below 5% throughout September. SARS-CoV-2 percentage positivity ranged from 13.6-15.6% nationally in the reporting period, having increased from 10.9% in the last week of August (week 35). Testing rates were...
Influenza A and B detection rates remained below 2% during August, with the influenza season officially having ended in July (NICD Weekly Respiratory Pathogens Surveillance Report, week 34 of 2023). Surveillance is ongoing to determine whether a second influenza peak...
Influenza, respiratory syncytial virus and SARS-CoV-2 Influenza A detection rates peaked in week 21 (week ending 28 May) and then decreased each week throughout June, with the percentage positivity dropping to 12% in the last week of June. Influenza A/H3 continued to...
Background: Mumps virus (MV), a single-stranded RNA virus of the paramyxoiridae family, is highly contagious and is most commonly associated with parotitis. There has been a significant increase in the amount of mumps cases nationally in 2023. For patients...
The polymerase chain reaction (PCR) test for the detection of SARS-CoV-2 in respiratory specimens is an essential tool in screening and diagnosing COVID-191. Clinical virology laboratories often make use of a diverse repertoire of testing platforms with varying...
On 26 November 2021 the WHO designated the new SARS-CoV-2 lineage B.1.1.529, now named Omicron, a variant of concern. Much is still unknown about Omicron and it is expected that the variant’s real world impact will become clearer over the next weeks. What is Omicron?...